click below
click below
Normal Size Small Size show me how
Chapter 35
Comfort and Pain Management
Term | Definition |
---|---|
Acute Pain | episode of pain that lasts from seconds to less than 6 months |
Addiction | a pattern of compulsive use of addictive substances for means other than those prescribed |
Adjuvant | drugs typically used for other purposes, but also used to enhance the effect of opioids by providing additional pain relief |
Analgesic | pharmaceutical agent used to relieve pain |
Breakthrough Pain | temporary flare up of moderate to severe pain that occurs even when the patient is taking around the clock medication for persistent pain |
Chronic pain | episode of pain that lasts for 6 months or longer; may be intermittent or continuous |
Cutaneous pain | superficial pain usually involving the skin or subcutaneous tissue |
Dynorphin | the endorphin having the most potent analgesic effect |
Endorphins | morphine-like substances released by the body that appear to alter the perception of pain |
Enkephalins | opioids that are widespread throughout the brain and dorsal horn of the spinal cord and are believed to reduce pain sensation by inhibiting the release of substance P |
Exacerbation | period in chronic illness when the symptoms of the disease reappear |
Gate control Theory | theory that explains that excitatory pain stimuli carried by small - diameter nerve fibers can be blocked by inhibiting signals carried by large diameter nerve fibers |
Intractable | severe pain that is extremely resistant to relief measures |
Modulation | process by which the sensation of pain is inhibited or modified |
Neuromodulators | endogenous opioid chemical regulators that appear to have analgesic activity and alter pain perception |
Transmission | conduction of pain sensations from the side of an injury or inflammation along clear and unclear pathways to the spinal cord and then on to higher centers |
Visceral pain | pain originating in the internal organs in the thorax, cranium or abdomen |
Neuropathic pain | pain that results as a direct consequence of a lesion or disease affecting abnormal functioning of the peripheral nervous system (PNS) or central nervous system (CNS) |
Neurotransmitters | substances that either excite or inhibit target nerve cells |
Nociceptors | pain receptors |
Opioids | more correct term for narcotic analgesics since these drugs act by binding to opiate receptor sites in the central nervous system |
Pain threshold | amount of stimulation required before person experiences the sensation of pain |
Pain tolerance | point beyond which a person is no longer willing to endure pain (i.e. pain of greater duration or intensity) |
Perception | conscious process of organizing and interpreting data from the senses into meaningful information |
Phantom pain | sensation without demonstrable physiologic or pathologic substance; commonly observed after the amputation of a limb |
Physical dependence | phenomenon in which the body physiologically becomes accustomed to an opioid and suffers withdrawal symptoms if the opioid suddenly removed or the dose is rapidly decreased |
Placebo | Latin word meaning "I shall please" an inactive substance that gives satisfaction to the person using it |
Psychogenic pain | pain for which no physical cause can be identified |
Referred pain | pain in an area removed from that in which stimulation has its origin |
Remission | period in a chronic illness when the disease is present, but the person does not experience symptoms of the disease |
Somatic pain | pain originating in structures in the body's external wall |
Tolerance | occurrence of the body's becoming accustomed to an opioid and needing a larger dose each time for pain relief |
Trunsduction | activation of pain receptors |